News
7hon MSN
For people with advanced heart failure, left ventricular assist devices, or LVADs, can be a literal lifesaver.
9hon MSN
SGLT2 inhibitors have become a major drug used to treat diabetes, heart failure, and chronic kidney disease. However, there ...
Too many supplements and medications can be hard on your liver. A doctor explains how to get the most bang for your buck and ...
4h
Amazon S3 on MSNHow to self manage congestive Heart FailureTrump keeps control of California National Guard for now after appeals court blocks order North Korea says repaired destroyer has launched, a claim met with outside skepticism Watch quick-thinking ...
56m
News-Medical.Net on MSNEmpagliflozin preserves kidney function in heart attack patientsBottom line of study: SGLT2 inhibitors have become a major drug used to treat diabetes, heart failure, and chronic kidney ...
Thousands could be saved by making this small change to heart failure treatment - Giving medication up to a year earlier ...
If you experience any symptoms of heart disease, you should talk with a doctor right away. There are treatment options available. When it comes to heart failure, there are several varieties and ...
This review discusses the role of aldosterone antagonists in the treatment of heart failure, including an overview of aldosterone’s role in the pathology of heart failure, the benefits of each ...
Several observations from preclinical and short-term clinical studies support a role for sildenafil in the treatment of heart failure patients. The following discussion briefly considers each of ...
Medications are available for depression and anxiety disorders in people with heart failure, which may, in turn, help improve your sleep. Psychotherapy may also be effective. A traditional type of ...
Bayer's mineralocorticoid receptor antagonist (MRA) Kerendia hit the mark as a treatment for a common form of heart failure in the FINEARTS-HF study, setting up regulatory approvals, but there is ...
Eli Lilly's tirzepatide has been shown to significantly cut cardiovascular risks in patients with obesity and a form of heart failure with few treatment options, in another big win for the GLP-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results